KR840003811A - 안정하고 기포성인 질좌약 조성물 - Google Patents

안정하고 기포성인 질좌약 조성물 Download PDF

Info

Publication number
KR840003811A
KR840003811A KR1019830000893A KR830000893A KR840003811A KR 840003811 A KR840003811 A KR 840003811A KR 1019830000893 A KR1019830000893 A KR 1019830000893A KR 830000893 A KR830000893 A KR 830000893A KR 840003811 A KR840003811 A KR 840003811A
Authority
KR
South Korea
Prior art keywords
foamable
stable
vaginal suppository
suppository compositions
formalin
Prior art date
Application number
KR1019830000893A
Other languages
English (en)
Other versions
KR890000730B1 (ko
Inventor
도시오 구로베
Original Assignee
나이또오 유우지
에자이 가부시기 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나이또오 유우지, 에자이 가부시기 가이샤 filed Critical 나이또오 유우지
Publication of KR840003811A publication Critical patent/KR840003811A/ko
Application granted granted Critical
Publication of KR890000730B1 publication Critical patent/KR890000730B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Abstract

내용 없음

Description

안정하고 기포성인 질좌약 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 나프탈렌설폰산과 포르말린의 축합반응에 의하여 제조된 고중합도의 나프탈렌설폰산-포르말린의 축합물을 함유하는 반응혼합물에 크라프트 펄프폐액으로 제조한 로진산에스텔을 전체 중량의 1-2% 배합하고 전체 중량의 4-18%의 염화칼슘을 배합하여 시멘트에 0.1-5.0% 배합사용하게된 시멘트 분산제 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830000893A 1982-03-05 1983-03-05 안정한 발포성 질 좌약 조성물의 제조방법 KR890000730B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57034034A JPS58152809A (ja) 1982-03-05 1982-03-05 安定な発泡性「膣」坐剤
JP34034 1982-03-05

Publications (2)

Publication Number Publication Date
KR840003811A true KR840003811A (ko) 1984-10-04
KR890000730B1 KR890000730B1 (ko) 1989-04-03

Family

ID=12403050

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830000893A KR890000730B1 (ko) 1982-03-05 1983-03-05 안정한 발포성 질 좌약 조성물의 제조방법

Country Status (7)

Country Link
US (1) US4853211A (ko)
EP (1) EP0088394B1 (ko)
JP (1) JPS58152809A (ko)
KR (1) KR890000730B1 (ko)
CA (1) CA1217719A (ko)
DE (1) DE3364238D1 (ko)
DK (1) DK161736C (ko)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542020A (en) * 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
US4999342A (en) * 1988-08-16 1991-03-12 Ortho Pharmaceutical Corporation Long lasting contraceptive suppository composition and methods of use
GR1000603B (el) * 1989-08-16 1992-08-26 Ortho Pharma Corp Μακρας διαρκειας αντισυλληπτικη συνθεσις υποθετου και μεθοδοι χρησεως.
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE4400375C2 (de) * 1994-01-08 1996-10-31 Schmittmann Hans Bernd Verwendung von erregerabtötend wirkenden Schäumen
FR2725371B1 (fr) * 1994-10-05 1997-08-29 Techni Pharma Nouveau procede de fabrication de suppositoires
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
MA24525A1 (fr) * 1997-04-14 1998-12-31 Procter & Gamble Particule detergente
EP0872544A1 (en) * 1997-04-14 1998-10-21 The Procter & Gamble Company Dry effervescent granules and granular compositions comprising the same
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6576250B1 (en) * 1998-03-27 2003-06-10 Cima Labs Inc. Pharmaceutical compositions for rectal and vaginal administration
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US20070178139A1 (en) * 1998-11-18 2007-08-02 Yankov Vladimir I Vaginally administratable progesterone-containing tablets and method for preparing same
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
US6426111B1 (en) 2000-06-02 2002-07-30 Gerald Phillip Hirsch Effervescent mixtures and methods of making
US6740333B2 (en) * 2000-07-07 2004-05-25 Anestic Aps Suppository and composition comprising at least one polyethylene glycol
CA2345014C (en) * 2000-08-11 2010-04-20 Unilever Plc Packaged cosmetic effervescent cleansing pillow
CA2422424C (en) * 2000-09-19 2009-12-01 Cima Labs, Inc. Pharmaceutical compositions for rectal and vaginal administration
WO2002089823A1 (fr) * 2001-04-27 2002-11-14 Kyoto Pharmaceutical Industries, Ltd. Methode de conservation pour un suppositoire
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
WO2005065317A2 (en) 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
US7862833B2 (en) * 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
NZ548216A (en) * 2003-12-31 2010-02-26 Cima Labs Inc Generally linear effervescent oral fentanyl dosage form and methods of administering
CA2654152A1 (en) * 2006-06-02 2007-12-13 Pear Tree Women's Health Care Method of treating atrophic vaginitis
EP1872807A1 (en) * 2006-06-30 2008-01-02 Scil Technology GmbH Biomaterial containing degradation stabilized polymer
WO2008015138A2 (en) * 2006-08-03 2008-02-07 Ciba Holding Inc. Composition for improving wettability of surfaces
CA2665841C (en) 2006-10-09 2016-04-05 Charleston Laboratories, Inc. Pharmaceutical compositions
AU2008300199B2 (en) * 2007-09-20 2013-09-12 Lapidot Medical Import And Marketing Ltd Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endrometriosis, adenomyosis and related disorders by mifepristone
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
US20100087402A1 (en) * 2008-09-29 2010-04-08 Vivus, Inc. Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders
UA105375C2 (uk) 2009-01-09 2014-05-12 Егіш Дьйодьсердьяр Нільваношан Мюкеде Ресвеньтаршашаг Спосіб виготовлення вагінального супозиторія
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
JPWO2015129800A1 (ja) * 2014-02-26 2017-03-30 セオリアファーマ株式会社 ジオクチルソジウムスルホサクシネート耳鼻科用液剤
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
US10966924B2 (en) * 2018-09-04 2021-04-06 Babak Ghalili Veterinary cannabinoid, menthol and anesthetic compositions and methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1878766A (en) * 1928-11-26 1932-09-20 Gilbert F Fitzgerald Suppository for treating vaginal conditions
US3062715A (en) * 1953-11-18 1962-11-06 George S Pfaus Vaginal tablet
US3121663A (en) * 1956-02-09 1964-02-18 Plough Lab Inc Carbon dioxide releasing laxative suppository
DE2213604C2 (de) * 1972-03-21 1975-08-14 Merz & Co, 6000 Frankfurt Vaginalzäpfchen zur Empfängnisverhütung
NL7302521A (en) * 1973-02-23 1974-08-27 Foaming, effervescent capsules - contg. therapeutic agents for rectal and vaginal use
US4036228A (en) * 1975-09-11 1977-07-19 Alza Corporation Osmotic dispenser with gas generating means
DE2602297B1 (de) * 1976-01-22 1977-01-13 Merz & Co Vaginalzaepfchen zur empfaengnisverhuetung mit einem gehalt an milchalbumin
CA1067079A (en) * 1976-07-22 1979-11-27 Yamanouchi Pharmaceutical Co. Nitrogen-containing heterobicyclic compounds
US4187286A (en) * 1979-01-02 1980-02-05 G&W Laboratories, Inc. Contraceptive suppository
US4322399A (en) * 1979-10-19 1982-03-30 Ortho Pharmaceutical Corporation Vaginal suppository

Also Published As

Publication number Publication date
DE3364238D1 (en) 1986-07-31
JPS58152809A (ja) 1983-09-10
CA1217719A (en) 1987-02-10
EP0088394B1 (en) 1986-06-25
EP0088394A3 (en) 1983-10-12
DK105583A (da) 1983-09-06
DK105583D0 (da) 1983-03-01
DK161736B (da) 1991-08-12
EP0088394A2 (en) 1983-09-14
US4853211A (en) 1989-08-01
DK161736C (da) 1992-01-27
KR890000730B1 (ko) 1989-04-03

Similar Documents

Publication Publication Date Title
KR840003811A (ko) 안정하고 기포성인 질좌약 조성물
KR830003528A (ko) 섬유형성 코폴리에스테르
KR890007722A (ko) 엑시폰과 수요성중합체를 함유하는 약학조성물
KR860002436A (ko) 콘크리이트 혼합재료
KR840003225A (ko) 시멘트 팽창재
KR840004041A (ko) 시멘트 분산제 조성물 및 시멘트 분산방법
KR860001172A (ko) 제강스라그의 이용방법
KR880010675A (ko) 느릅나무 껍질을 주재로 한 차(茶)의 제조방법
KR850001526A (ko) 분말상 섬유소 글리코올 칼슘의 제조법
KR840000593A (ko) Tpa와 eg 혼합물의 유동성을 개선하는 방법
KR830001335A (ko) 알긴 및 tkp의 신규 혼합물
KR870011056A (ko) 무수축 시멘트 조성물
KR930002268A (ko) 플라이 애쉬(Fly Ash)와 모래를 혼합한 시멘트 조성물
KR830006134A (ko) 자체수평성 접착조성물
KR850005383A (ko) 마사토를 이용한 벽돌 제조방법
KR840001816A (ko) 청량음료수의 제조방법
KR890017187A (ko) 칼라 시멘트 조성물
KR850007972A (ko) 시멘트 방수제의 제조법
JPS55142092A (en) Additive for slurry fuel
KR870002274A (ko) 슬래그(slag)연화제
KR860001026A (ko) 도자기재 가열용기의 원료 조성방법
KR860003176A (ko) 연탄재를 이용한 건자재의 제조방법
KR840002434A (ko) 불연, 내수 스톤(stone) 벽재 페인트의 제조 방법
KR850001523A (ko) 토양(土壤)등 경화용(硬化用) 시멘트 조성물
KR840001529A (ko) 불로운 유지방수제

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19960327

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee